Shionogi

Japanese Company Says New Oral COVID-19 Drug Ensitrelvir Achieves Primary Endpoint

1456d BY Ellen Wan and Angela Bright
Japan’s Shionogi Says COVID-19 Pill Shows Rapid Clearance of Virus

1662d BY Reuters
Japan-Based Shionogi’s COVID-19 Drug Associated With Birth Defects: Bloomberg

1674d BY Benzinga
Japan’s Shionogi Seeks Approval for COVID-19 Pill

1721d BY Reuters
Japan’s Shionogi Starts Phase III Clinical Trial in Vietnam for COVID-19 Vaccine

1782d BY Reuters